Impact of Hypoxia on Carbon Ion Therapy in Glioblastoma Cells: Modulation by LET and Hypoxia-Dependent Genes.
carbon ions
erythropoietin
glioblastoma
heavy ion radiotherapy
hypoxia
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
23 Jul 2020
23 Jul 2020
Historique:
received:
11
06
2020
revised:
15
07
2020
accepted:
19
07
2020
entrez:
29
7
2020
pubmed:
29
7
2020
medline:
29
7
2020
Statut:
epublish
Résumé
Tumor hypoxia is known to limit the efficacy of ionizing radiations, a concept called oxygen enhancement ratio (OER). OER depends on physical factors such as pO
Identifiants
pubmed: 32718037
pii: cancers12082019
doi: 10.3390/cancers12082019
pmc: PMC7464439
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Curr Mol Med. 2009 May;9(4):442-58
pubmed: 19519402
Brain Res. 2011 Jan 31;1371:7-15
pubmed: 21108935
Cancer Radiother. 2010 Jan;14(1):34-41
pubmed: 20004126
Cancer Med. 2014 Aug;3(4):812-24
pubmed: 24810477
Biochim Biophys Acta. 2009 Dec;1796(2):216-29
pubmed: 19682551
Cancers (Basel). 2019 Apr 03;11(4):
pubmed: 30987217
Front Med (Lausanne). 2019 Jun 12;6:117
pubmed: 31249831
Cancer Lett. 2015 Apr 28;360(1):10-6
pubmed: 25657111
J Radiat Res. 2007 Jul;48(4):317-25
pubmed: 17548940
Radiat Oncol. 2017 Dec 29;12(1):208
pubmed: 29287602
Int J Radiat Biol. 2009 Sep;85(9):715-28
pubmed: 19728191
Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):603-16
pubmed: 14751534
Radiat Res. 2000 Nov;154(5):485-96
pubmed: 11025645
Cancers (Basel). 2019 Jan 18;11(1):
pubmed: 30669417
J Radiat Res. 2013 Jan;54(1):18-26
pubmed: 22915783
Br J Radiol. 1953 Dec;26(312):638-48
pubmed: 13106296
Cancer Commun (Lond). 2019 Feb 20;39(1):5
pubmed: 30786916
BMC Cancer. 2010 Nov 04;10:605
pubmed: 21050481
Prog Neurol Surg. 2018;32:57-65
pubmed: 29990974
Invest Ophthalmol Vis Sci. 2015 May;56(5):3085-94
pubmed: 26024093
Oncol Rep. 2010 Dec;24(6):1629-36
pubmed: 21042761
Mol Med Rep. 2015 Mar;11(3):1573-81
pubmed: 25376370
Br J Cancer. 2017 May 9;116(10):1340-1349
pubmed: 28407653
Neuro Oncol. 2017 Jul 1;19(7):887-896
pubmed: 28339582
Sci Rep. 2015 Nov 24;5:17016
pubmed: 26596243
Lancet Oncol. 2009 May;10(5):459-66
pubmed: 19269895
Int J Oncol. 2014 Jun;44(6):2121-31
pubmed: 24676782
JCI Insight. 2019 Jan 24;4(2):
pubmed: 30674721
J Theor Biol. 2016 Apr 7;394:93-101
pubmed: 26807808
Mol Neurobiol. 2015 Aug;52(1):626-37
pubmed: 25249341
Cell Tissue Res. 1991 Jul;265(1):73-81
pubmed: 1655272
BMC Cancer. 2010 Oct 06;10:533
pubmed: 20925951
Onco Targets Ther. 2018 May 22;11:3003-3011
pubmed: 29872312
Int J Radiat Biol. 2009 Feb;85(2):126-37
pubmed: 19280465
J Radiat Res. 2019 Mar 1;60(2):178-188
pubmed: 30624699
J Radiat Res. 2019 Jan 1;60(1):59-68
pubmed: 30452663
J Radiat Res. 2016 Aug;57 Suppl 1:i99-i105
pubmed: 26983985
Expert Opin Drug Discov. 2019 Jul;14(7):667-682
pubmed: 31070059
Int J Radiat Biol. 2013 Jun;89(6):454-61
pubmed: 23363301
Front Oncol. 2015 Aug 11;5:184
pubmed: 26322274
Cell Death Dis. 2010 Jul 29;1:e60
pubmed: 21364665
Exp Cell Res. 2011 Oct 1;317(16):2321-32
pubmed: 21749867
Radiat Oncol. 2017 Dec 1;12(1):193
pubmed: 29195506
Neuro Oncol. 2013 Jan;15(1):4-27
pubmed: 23136223
Neuro Oncol. 2015 Oct;17 Suppl 4:iv1-iv62
pubmed: 26511214
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Cell Cycle. 2008 Aug 15;7(16):2553-61
pubmed: 18719373
FASEB J. 2014 Mar;28(3):1412-21
pubmed: 24347608
Oncotarget. 2015 Feb 10;6(4):2101-19
pubmed: 25544764